An exciting topic at the recent ANR2016 research conference for neuroblastoma was research into developing blood tests for cancer cells and cancer DNA.

These would offer a more effective, less painful alternative to traditional biopsies. Our Deputy Director, Prof Murray Norris explains what the fuss is about in an article in LabOnline this month:

“Imagine a future where simple blood tests provide an efficient, painless and non-invasive way to track changes in cancer patients and guide treatment.

For children with cancer, it’s their parents who have to make difficult decisions about invasive tests. Fortunately, we’re on our way to a future of simpler testing for one of childhood’s more common cancers — neuroblastoma — as we heard at a recent international research conference in Cairns.

Neuroblastoma is a childhood cancer of specialised nerve cells which are involved in the development of the nervous system and other tissues. Neuroblastoma can occur in the chest, neck and near the spine; however, it most commonly occurs in the adrenal glands, which are located on top of the kidneys. The average age of diagnosis is just two years old  .  .  .

Read the full article here.



Sign up for blog updates!

Every month, get a list of the latest posts in your inbox.

Thank you for subscribing.

Something went wrong.

Sign up for blog updates!

Every month, get a list of the latest posts in your inbox.

Thank you for subscribing.

Something went wrong.

Send this to a friend